Yes-associated protein 1 (YAP1), as a direct downstream effector of the tumor suppressive hippo pathway, has been found to be elevated in various cancers, such as liver cancer [16], colorectal cancer [17], ovarian cancer [18], gastric cancer [19] and non–small-cell lung cancer [20]. This evidence concerns the gene YAP1 and cancer.